Atlas Trials

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

Clinical trial NCT00566722 · COMPLETED

Trial details

NCT number
NCT00566722
Sponsor
Abbott
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Psoriasis
Start date
2008-01-01
Primary completion
2009-04-01
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.